The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Metronomic therapy for heavily pretreated relapsed/refractory multiple myeloma (RRMM).
Xenofon Papanikolaou
No relevant relationships to disclose
Jackie Szymonifka
No relevant relationships to disclose
Alan Mitchell
No relevant relationships to disclose
Jason Keller
No relevant relationships to disclose
Christoph Johann Heuck
No relevant relationships to disclose
Sarah Waheed
No relevant relationships to disclose
Saad Zafar Usmani
No relevant relationships to disclose
Bijay Nair
No relevant relationships to disclose
Frits Van Rhee
No relevant relationships to disclose
Stephen Charles Medlin
No relevant relationships to disclose
Clyde Bailey
No relevant relationships to disclose
Nathan Petty
No relevant relationships to disclose
Antje Hoering
No relevant relationships to disclose
John Crowley
No relevant relationships to disclose
Bart Barlogie
No relevant relationships to disclose